You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
McKinsey
Moodys
Express Scripts
Harvard Business School

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Litigation Details for Sanofi v. Lupin Atlantis Holdings SA (D. Del. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Sanofi v. Lupin Atlantis Holdings SA
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Sanofi v. Lupin Atlantis Holdings SA (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2016-10-03 140 hospitalization. The '900 patent is similar to, but not identical to, U.S. Patent 8,410,167 B2, which I construed…of multiple terms in U.S. Patent No. 9,107,900 B2 ("the '900 patent"). The Court has considered…Plaintiffs brought this patent infringement action alleging infringement of the '900 patent. (D.I. 1). The…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which …construing patent claims, a court considers the literal language of the claim, the patent specification External link to document
2017-10-23 212 invalidity with respect to U.S. Patent No. 9,107,900 (the '"900 patent"). I held… sells any patented invention, within the United States ... during the term of the patent .... "…defendant knew of the patent and knew as well that 'the induced acts constitute patent infringement."… Defendants argue that the patented uses described by the '900 patent do not correlate with the …quot;Plaintiffs") bring this consolidated patent infringement case against Defendants Watson Laboratories External link to document
2015-10-19 27 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,107,900 B2; . (Kraftschik, … 21 May 2015 1:15-cv-00415 830 Patent None District Court, D. Delaware External link to document
2015-05-21 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,318,800 B2; 8,410,167 B2; (… 21 May 2015 1:15-cv-00415 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Moodys
Colorcon
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.